Intrapleural use of tissue plasminogen activator and DNase in pleural infection
BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...
Hoofdauteurs: | Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2011
|
Gelijkaardige items
-
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
door: Rahman, N, et al.
Gepubliceerd in: (2011) -
PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
door: Rahman, N, et al.
Gepubliceerd in: (2009) -
The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
door: Kanellakis, N, et al.
Gepubliceerd in: (2018) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
door: Kanellakis, N, et al.
Gepubliceerd in: (2019) -
Intrapleural streptokinase for pleural infection.
door: Maskell, N, et al.
Gepubliceerd in: (2006)